Pharma & Bio
Technology
G2G Bio Makes a Bold Move into the Next-Generation Obesity Treatment Market with Its Long-Acting Platform
#G2G Bio, a drug delivery system (DDS) platform company, is accelerating its push into the next-generation obesity treatment market by leveraging its long-acting drug delivery technology. G2G Bio is s…
Technology
Partnership with a Leading U.S. AI Healthcare Company Imminent... Signaling a Quantum Leap in Earnings [In-Depth Look at Medipixel ③]
For medical artificial intelligence (AI) companies, the domestic market is viewed as a valuable testing ground and home turf for validating their technological capabilities. However, to achieve sustai…
Technology
The “Lock-in Effect” Created by a “7-Second” Innovation… Non-Insured Services Take Flight [In-Depth Look at Medipixel ②]
The cardiovascular catheterization lab, where every second counts in emergency situations, is considered a veritable silent battlefield. In this high-pressure environment, where a patient’s life hinge…
Technology
CEO Song Gyo-seok: "We pivoted from lung cancer to cardiovascular AI diagnostics... and crossed the 'Valley of Death'" [In-Depth Look at Medipixel ①]
In the spring of 2016, the match between Lee Sedol, a 9-dan professional Go player, and the artificial intelligence (AI) program AlphaGo sent shockwaves around the world. While for some it was merely …
Business·Industry
'Cumulative Technology Transfer Value Reaches 3 Trillion Won': Aimed Bio Sees a Series of ADC Technology Transfers
#AimedBio is drawing attention for achieving a cumulative total of 3 trillion won in technology transfer deals while still in the unlisted and preclinical stages. AimedBio was listed on the KOSDAQ mar…
Technology
'Insurance for Baldness?' Policy Hopes Drive 30% Surge in JW Pharma [K-bio Pulse]
The government’s plan to review health insurance coverage for hair-loss treatments triggered sharp price movements in Korea’s pharmaceutical and biotech sectors on June 15. Hair-loss drug manufacturer…
Technology
“Hair Loss Stock Day”… JW New Drug, Hyundai Pharmaceutical, and Samik Pharmaceutical Rise on Policy Momentum [Bio Spotlight]
On the 15th, the domestic pharmaceutical and biotech sector was in turmoil following news that the government is considering covering hair loss treatments under the national health insurance system. W…
Technology
"Hiring 'Robot Researchers Who Work Nonstop'... JW Pharmaceutical Sets a New Standard for Clinical Trials"
Autonomous laboratories utilizing artificial intelligence (AI) and robots are revolutionizing new drug development. We have entered an era where automation extends beyond simple, repetitive tasks to i…
Business·Industry
HLB, 'Ahead of Approval for New Liver Cancer Drug,' May Substitute Written Submission for CMC Inspection… Industry Skepticism
With the decision on whether #HLB’s new liver cancer drug, Riboceranib, will receive U.S. approval just over a month away, the possibility of a Regulatory Review Information (RLI) report has been rais…
Lifestyle
'Structural Reform Success' Y2Solution Forecasts Doubling of This Year's Earnings
#Y2Solution is continuing its rapid growth toward doubling its performance this year, having successfully shed the constraints of traditional manufacturing and transformed itself into a high-tech comp…